1. Long‐term outcomes of metabolic surgery in overweight and obese patients with type 2 diabetes in<scp>Asia</scp>
- Author
-
Yen Kuang Lin, Simon Kin Hung Wong, Davide Lomanto, Weu Wang, Yen-Hao Su, Yu Min Huang, Kazunori Kasama, Wei-Jei Lee, Kyoung Yul Hur, Tien Chou Soong, Muffazal Lakdawala, Kuo-Ting Lee, Ming Hsien Lee, and Anton Cheng
- Subjects
medicine.medical_specialty ,Asia ,Endocrinology, Diabetes and Metabolism ,Gastric Bypass ,Bariatric Surgery ,Blood sugar ,030209 endocrinology & metabolism ,Type 2 diabetes ,030204 cardiovascular system & hematology ,Overweight ,Body Mass Index ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Internal medicine ,Diabetes mellitus ,Statistical significance ,Internal Medicine ,medicine ,Humans ,Obesity ,business.industry ,medicine.disease ,Obesity, Morbid ,Treatment Outcome ,Blood pressure ,Diabetes Mellitus, Type 2 ,medicine.symptom ,business ,Body mass index - Abstract
AIM To assess the outcomes of metabolic surgery in overweight and obese patients in Asia with type 2 diabetes (T2D). MATERIALS AND METHODS The treatment outcomes of 1999 patients from the Asian Diabetes Surgery Summit database were analysed. The changes in treatment effects across time were assessed with respect to the surgical procedures performed by using generalized estimating equations. RESULTS The most commonly performed procedure was the single-anastomosis gastric bypass (32.6%). Weight (from 106.2 ± 25.1 to 77.9 ± 18.8 kg), body mass index (BMI; from 38.7 ± 7.9 to 28.5 ± 5.9 kg/m2 ), blood sugar (from 9.3 ± 4.1 to 5.7 ± 1.8 mmol/L) and HbA1c (from 8.4% ± 1.8% to 6.0% ± 1.1%) significantly improved from baseline to 1 year (P
- Published
- 2020
- Full Text
- View/download PDF